NewsFeed
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Zeinab Kazemianpour: 1 Embryo, 2 Different Biopsy Strategies
Sep 21, 2026, 17:12

Zeinab Kazemianpour: 1 Embryo, 2 Different Biopsy Strategies

Zeinab Kazemianpour, Clinical Embryologist at Nikan Hospital, shared on LinkedIn:

“One embryo, two different biopsy strategies.

Have you ever wondered why some embryos are biopsied on Day 3, while others are biopsied at the blastocyst stage?

On ‘Day 3’, a single blastomere can be removed from an early cleavage-stage embryo.

The main advantages are the early timing and relatively simple cell isolation.

However, the small amount of DNA and the possibility of mosaicism may sometimes lead to inconclusive or less representative results.

By ‘Day 5/6’, the embryo has reached the blastocyst stage.

Several ‘trophectoderm (TE) cells’ can be collected while leaving the ‘inner cell mass (ICM)’ untouched.

The larger sample provides more DNA for genetic testing, including ‘PGT-A, PGT-M and PGT-SR’.

After blastocyst biopsy, the embryo is usually vitrified while the genetic analysis is performed and can be transferred later in a frozen embryo transfer cycle.”

Zeinab Kazemianpour

Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.